Fuhao Chu
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
- Plant-based Medicinal Research
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Natural product bioactivities and synthesis 9
-
- Traditional Chinese Medicine Analysis 9
- Co-authors
- Haimin Lei (26 shared papers)Penglong Wang (21 shared papers)Xia Ding (11 shared papers)Bing Xu (15 shared papers)Zeqi Su (9 shared papers)Yu‐Zhong Zhang (13 shared papers)Nadia Johnson (5 shared papers)Wenqiang Yan (8 shared papers)
In The Last Decade
Fuhao Chu
46 papers receiving 862 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 178
- Complementary and alternative medicine 144
- Toxicology 29
- Molecular Biology 375
- Gastroenterology 27
Countries citing papers authored by Fuhao Chu
This map shows the geographic impact of Fuhao Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuhao Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuhao Chu more than expected).
Fields of papers citing papers by Fuhao Chu
This network shows the impact of papers produced by Fuhao Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuhao Chu. The network helps show where Fuhao Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuhao Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 74 | |
| 2 | 2021 | 70 | |
| 3 | 2021 | 66 | |
| 4 | 2020 | 49 | |
| 5 | 2019 | 36 | |
| 6 | 2014 | 34 | |
| 7 | 2017 | 32 | |
| 8 | 2021 | 29 | |
| 9 | 2017 | 28 | |
| 10 | 2015 | 27 | |
| 11 | 2020 | 25 | |
| 12 | 2013 | 24 | |
| 13 | 2020 | 24 | |
| 14 | 2024 | 23 | |
| 15 | 2016 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2018 | 21 | |
| 18 | 2022 | 20 | |
| 19 | 2013 | 19 | |
| 20 | 2016 | 18 |
About Fuhao Chu
Fuhao Chu is a scholar working on Molecular Biology, Complementary and alternative medicine, Pharmacology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 883 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (9 papers), Natural product bioactivities and synthesis (9 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Polyoxometalates: Synthesis and Applications (3 papers), Gastrointestinal motility and disorders (2 papers), Hepatitis C virus research (2 papers), Tannin, Tannase and Anticancer Activities (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Pharmacology (178 citations), Complementary and alternative medicine (144 citations), Toxicology (29 citations), Molecular Biology (375 citations) and Gastroenterology (27 citations). Fuhao Chu has collaborated with scholars based in China and Macao. Frequent co-authors include Haimin Lei, Penglong Wang, Xia Ding, Bing Xu, Zeqi Su, Yu‐Zhong Zhang, Nadia Johnson, Wenqiang Yan, Yicong Li and Chenze Zhang. Their work appears in journals such as Molecules, Journal of Ethnopharmacology, Frontiers in Pharmacology, International Journal of Molecular Sciences and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.